Oncolytic virus M1 reinvigorates CD8&lt;sup&gt;+&lt;/sup&gt; T-cell immunity against glioblastoma through B-cell-dependent antigen cross-presentation in the spleen. This evidence concerns the gene CD8A and glioblastoma.